Astrazeneca Pharma India reports standalone net profit of Rs 8.67 crore in the December 2015 quarter
Sales rise 33.70% to Rs 144.56 crore
Net profit of Astrazeneca Pharma India reported to Rs 8.67 crore in the quarter ended December 2015 as against net loss of Rs 13.41 crore during the previous quarter ended December 2014. Sales rose 33.70% to Rs 144.56 crore in the quarter ended December 2015 as against Rs 108.12 crore during the previous quarter ended December 2014. ParticularsQuarter EndedDec. 2015Dec. 2014% Var.Sales144.56108.12 34 OPM %8.05-9.38 -PBDT13.11-9.04 LP PBT8.67-13.41 LP NP8.67-13.41 LPPowered by Capital Market - Live News